Recombinant Human G-CSF (carrier-free)

Pricing & Availability
Regulatory Status
RUO
Other Names
Granulocyte-Colony Stimulating Factor, CSF3, CSF-β
G-CSF_Human_030212
M-NSF-60 cell proliferation induced by human G-CSF.
  • G-CSF_Human_030212
    M-NSF-60 cell proliferation induced by human G-CSF.
Cat # Size Price Quantity Check Availability
578602 10 µg $218.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
578604 25 µg $440.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
578606 100 µg $1167.00
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Human G-CSF was cloned from a human squamous carcinoma cell line and is the key hematopoietic cytokine involved in the control of neutrophil production. Therefore, it is a critical regulator of innate immunity against bacterial infections. G-CSF mobilizes stem cells indirectly by down-regulating the expression of CXCL12 on marrow osteoblasts and by releasing neutrophil and monocyte proteolytic enzymes, including neutrophil elastase, cathepsin G, and matrix metalloproteinase-9, which in turn degrade important HSC trafficking and adhesion molecules c-kit, VCAM-1, and CXCR4. In addition, G-CSF possesses immunosuppressive effects on monocytes/macrophages, dendritic cells, and T lymphocytes. The receptor for G-CSF is expressed not only in hematopoietic cells; it is also expressed in cardiomyocytes, skeletal muscle, and neurons. G-CSF influences mouse skeletal muscle development and regeneration by stimulating myoblast proliferation. In vitro, G-CSF displays strong antiapoptotic activity in neuronal cells.

Technical data sheet

Product Details

Source
Human G-CSF, amino acids Thr27-Pro200 (Accession# BC033245.1), was expressed in 293E cells.
Molecular Mass
The 174 amino acid recombinant protein has a predicted molecular mass of 18.6 kD. The DTT-reduced and the non-reduced proteins migrate at approximately 20 kD by SDS-PAGE. The N-terminal amino acid is Thr.
Purity
>95%, as determined by Coomassie stained SDS-PAGE.
Formulation
0.22 µm filtered protein solution is in PBS.
Endotoxin Level
Less than 0.01 ng per µg cytokine as determined by the LAL method.
Concentration
10 and 25 µg sizes are bottled at 200 µg/mL. 100 µg size and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.
Storage & Handling
Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at -20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 µg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week and stored at -20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles.
Activity
ED50 =0.02 - 0.08 ng/ml, corresponding to a specific activity of 1.25 - 5.0 x 107 units/mg, as determined by M-NFS60 cell proliferation induced by human G-CSF in a dose dependent manner.
Application

Bioassay

Application Notes

BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue-ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are verified in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at tech@biolegend.com.

Product Citations
  1. Woodley K, et al. 2023. Nat Commun. 14:2132. PubMed
  2. Samakkarnthai P, et al. 2023. Aging (Albany NY). 15:3331. PubMed
  3. , et al. 2019. J Immunother Cancer. 283:7. PubMed
  4. Paris J et al. 2019. Cell Stem Cell. 25(1):137-148 . PubMed
  5. Koh WH, et al. 2020. STAR Protoc. 1:100203. PubMed

Antigen Details

Structure
Heterodimer
Distribution
Macrophages, monocytes, neutrophils, fibroblasts, endothelial cells, epithelial cells, and bone marrow stromal cells.
Function
G-CSF acts on myeloid progenitor cells to stimulate survival, proliferation, and neutrophilic maturation; on mature neutrophils, G-CSF enhances survival, superoxido anion and alkaline phosphatase production, arachidonic acid release, and antibody dependent cellular cytotoxicity.
Interaction
Hematopoietic progenitor cells, neutrophilic granulocytes, monocytes, platelets, endothelial cells, trophoblastic cells, myoblasts, cardiomyocytes, cardiac fibroblasts, neurons, and some small cell lung carcinoma cell lines.
Ligand/Receptor
CD114 (G-CSFR).
Cell Type
Hematopoietic stem and progenitors, Embryonic Stem Cells
Biology Area
Cell Biology, Immunology, Innate Immunity, Stem Cells
Molecular Family
Growth Factors, Cytokines/Chemokines
Antigen References

1. Nagata S, et al. 1986. Nature 319:415.
2. Kim HK, et al. 2006. Blood 108:812.
3. Donahue RE, et al. 2009. Blood 114:2530.
4. Shimoji K, et al. 2010. Cell Stem Cell 6:227.
5. Martins A, et al. 2010. IUBMB Life 62:611.
6. Hara M, et al. 2011. J. Exp. Med. 208:715.

Gene ID
1441 View all products for this Gene ID
UniProt
View information about G-CSF on UniProt.org
Go To Top Version: 2    Revision Date: 08/19/2014

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

Login/Register
Forgot your password? Reset Password
Request an Account